USPTO serial 87808327
EVIDENCE MULTISTAT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 3, 2019
- Examiner
- FREEMAN, BREANNA SHALEISE
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with EVIDENCE MULTISTAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Crumlin, County Antrim, GB
Crumlin, County Antrim, GB
Crumlin, County Antrim, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas N. Masters
Douglas N. Masters LOEB & LOEB LLP321 N. Clark Street, Suite 2300Chicago, IL 60654United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific purposes; chemical reagents for scientific or medical research and for use in the analysis of food products; enzymes for use in scientific and medical research applications; protein arrays for use in scientific and medical research applications; diagnostic preparations for analysis of food products and water for scientific or research use; clinical diagnostic preparations for clinical or medical laboratory use; clinical diagnostic reagents for in vitro use for clinical or medical laboratory use; chemical reagents other than for medical or veterinary purpose, namely, chemical reagents for detection and monitoring of disease states in vitro; diagnostic proteins, namely, protein arrays for scientific and medical research featuring antibodies and antigens used for monitoring of disease states in vitro | ACTIVE | Nov 5, 2018 |
| 005 | Diagnostic preparations and substances for medical and veterinary purposes; diagnostic kits in the nature of clinical chemistry and immunology test kits for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiac, DOA, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; clinical diagnostic preparations, for medical or veterinary use; clinical diagnostic reagents for in vivo use for medical or veterinary purposes; diagnostic scanning agents for in vivo use for medical or veterinary purposes; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents formedical or veterinary purposes for the detection and monitoring of disease states including cardiac, DOA, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; medical diagnostic proteins, namely, protein arrays for medical diagnostic purposes featuring antibodies and antigens used for medical detection of disease states in vitro | ACTIVE | Nov 5, 2018 |
| 009 | Computer software for use in conjunction with in vitro diagnostic testing apparatus, namely, software for controlling medical and clinical sample processing, sample result reporting and test apparatus system robotics; computer hardware; computer programs for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems, namely, computer hardware and software for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems for use in conjunction with in vitro diagnostic testing apparatus, namely, computer software and hardware for controlling medical and clinical sample processing; downloadable computer databases and computer databases recorded on computer media for use in connection with in vitro diagnostic testing apparatus, namely, downloadable electronic data files featuring medical diagnostic sample results; scientific and optical apparatus and instruments, namely, a benchtop analytical system composed of barcode scanner and associated software for reading barcodes, a chemiluminescent detection system in the nature of instruments for measuring chemiluminescence, a temperature controlled incubator for laboratory use, and an electronic reagent and patient sample dispenser, suitable for protein and DNA arrays for or relating to the analysis, monitoring, research and/or reporting of clinical data, for use in vitro diagnostic testing procedures for clinical, veterinary, food and toxicological analysis; clinical analyzers for medical and veterinary use, namely, acidity analyzers, liquid analyzers, residual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs for laboratory use; light detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system not for medical purposes; parts and fittings for all the aforesaid goods, namely, replacement parts and fittings | ACTIVE | Nov 5, 2018 |
| 010 | Medical apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins and hormones; diagnostic apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; diagnostic imaging apparatus for medical use, namely, electromechanical diagnostic analyser utilizing a chemiluminescent detection system for use in in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; medical diagnostic testing apparatus and instruments for use in immunoassay procedures, namely, for use in the measurement of antibodies, immunoglobulins, hormones and drugs representing various drug classes; light detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system for medical purposes | ACTIVE | Nov 5, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Randox Laboratories Ltd
- Other trademarks owned by Randox Laboratories Ltd
- Other trademarks owned by Randox Laboratories Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named EVIDENCE MULTISTAT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 31, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 31, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 31, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 28, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 28, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 28, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 1, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 3, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 3, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 1, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 31, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 5, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 5, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 16, 2019 | IUAF | USE AMENDMENT FILED | — |
| Sep 16, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 19, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 22, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 22, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 2, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 18, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 12, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 31, 2018 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 19, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 1, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2018 | NWAP | NEW APPLICATION ENTERED | — |